Early-onset androgenic alopecia may identify men who are at high risk of developing prostate cancer (PCa), researchers reported online in Annals of Oncology.
Philippe Giraud, MD, PhD, of Paris Descartes University and the European Georges Pompidou Hospital in Paris, and colleagues conducted a 28-month study of 388 men who had been diagnosed with PCa between the ages of 46 and 84 years and 281 men without disease.
The PCa patients were twice as likely to have had androgenic alopecia at age 20 years compared with men without PCa. Early-onset alopecia was not associated with an earlier diagnosis of prostate cancer or with the development of more aggressive tumors.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.